The trajectory of companies tied to Sildenafil's legacy presents a complex investment scenario . While the initial success generated substantial profits , generic alternatives have significantly eroded https://adult528761.free-blogz.com/89386309/copyright-s-flagship-product-and-big-pharma-a-uncertain-opportunity